Tofacitinib for polyarteritis nodosa: a tailored therapy
- 24 August 2016
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 75 (12), 2214-2216
- https://doi.org/10.1136/annrheumdis-2016-209330
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokinesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2016
- Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritisAnnals Of The Rheumatic Diseases, 2015
- Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitorsAnnals Of The Rheumatic Diseases, 2015
- Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa VasculopathyThe New England Journal of Medicine, 2014
- In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2012